Clinicopathologic study of solid papillary carcinoma of breast

Chinese Journal of Pathology

Volumn 35, Issue 10, 2006, Pages 589-593

  Wei, Bing ^a   Bu, Hong ^a   Chen, Hui Jiao ^a   Zhang, Hong Ying ^a   Li, Xin Jun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Breast neoplasms; Carcinoma, papillary; Immunophenotyping

Indexed keywords

CALPONIN; CHROMOGRANIN A; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MUCIN; PROGESTERONE RECEPTOR; PROTEIN P63; PROTEIN PS2; SYNAPTOPHYSIN;

AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL COUNT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPH NODE DISSECTION; PAPILLARY CARCINOMA; PROTEIN EXPRESSION;

ACTINS; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, PAPILLARY; CHROMOGRANIN A; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-8; MASTECTOMY; MIDDLE AGED; SYNAPTOPHYSIN;

EID: 33845190872     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Maluf HM, Koerner FC. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol, 1995, 19:1237-1244.
2. Tavassoli FA, Devilee P, eds. World Health Organization classification of tumors. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press, 2003.
3. Lacroix-Triki M, Merry E, Voigt JJ, et al. Value of cytokeratin 5/6 immunostaining using D5/16B4 antibody in the spectrum of proliferative intraepithelial lesion of the breast. Acomparative study with CK34βE12 antibody. Virchows Arch, 2003, 442:548-554.
4. Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol, 2004, 28:1076-1091.
5. Azzopardi JG, Muretto P, Goddeeris P, et al. 'Carcinoid' tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology,1982, 6:549-569.
6. Cross AS, Azzopardi JG, Krausz T, et al. A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology, 1985, 9:21-37.
7. Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol, 1996, 20:921-943.
8. Rosen PP, Oberman HA, eds. Tumors of the mammary gland (Atlas of tumor pathology). 3rd Series. Washington DC: American Registry of Pathology, 1994.
9. Quinn CM, Ostrowski JL. Solid papillary carcinoma of the breast. Am J Surg Pathol, 1997, 21:256-258.
10. Sapino A, Righi L, Cassoni P, et al. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol, 2001, 14:768-776.
11. Tan PH, Lui GG, Chiang G, et al. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions. Histopathology, 2004, 45:343-351.